Aducanumab has been a complete failure and will likely be pulled from the market. Lecanemab is looking a little more promising but side effects significant - 17% of patients have brain bleeding.
Concern with Alzheimers has always been that AB buildup is the cause of the disease, however drugs that clear AB only show a modest benefit. Is this because it's 'too late, damage has been done' or is something else causing the decline? Nobody really knows yet.
Anyway, hopefully ARG may have some additional properties other than improving AB that make it more efficacious than the drugs getting approved now, and more safe!
- Forums
- ASX - By Stock
- Ann: Preclinical Data Shows ARG007 Inhibits a Cause of Alzheimers
Aducanumab has been a complete failure and will likely be pulled...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.0¢ |
Change
-0.020(2.41%) |
Mkt cap ! $102.9M |
Open | High | Low | Value | Volume |
85.0¢ | 85.5¢ | 81.0¢ | $80.99K | 98.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20011 | 81.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20011 | 0.810 |
4 | 94494 | 0.800 |
1 | 12500 | 0.795 |
1 | 7024 | 0.775 |
3 | 22739 | 0.770 |
Price($) | Vol. | No. |
---|---|---|
0.850 | 10000 | 1 |
0.855 | 20000 | 1 |
0.870 | 13395 | 3 |
0.880 | 2639 | 2 |
0.890 | 9752 | 2 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |